Figueira, J., Henriques, J., Amaro, M., Rosas, V., Alves, D., & Cunha-Vaz, J. (2017). A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study on the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND).
Chicago Style CitationFigueira, J., J. Henriques, M. Amaro, V. Rosas, D. Alves, and J. Cunha-Vaz. A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study On the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND). 2017.
MLA CitationFigueira, J., et al. A Nonrandomized, Open-Label, Multicenter, Phase 4 Pilot Study On the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (RESPOND). 2017.